News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Komal Jhaveri: OS Benefit with Adjuvant Abemaciclib in MonarchE Trial
Komal Jhaveri/X
Aug 30, 2025, 21:51

Komal Jhaveri: OS Benefit with Adjuvant Abemaciclib in MonarchE Trial

Komal Jhaveri, Clinical Director of Early Drug Development Service at Memorial Sloan Kettering Cancer Center and Patricia and James Cayne Chair for Junior Faculty, shared a post on LinkedIn:

“Fantastic news for patients!

OS benefit with adjuvant abemaciclib for 2 years for high-risk node-positive patients. Congratulations to everyone involved with the monarchE trial.

Awaiting details at an upcoming meeting.”

Read further.

More posts featuring MonarchE Trial on OncoDaily.

 

Abemaciclib cancer Komal Jhaveri Memorial Sloan Kettering Cancer Center monarchE trial OncoDaily Oncology
Special Coverage
Voices
Aug 30, 2025, 21:51
Komal Jhaveri: OS Benefit with Adjuvant Abemaciclib in MonarchE Trial
Societies
Aug 30, 2025, 21:48
Updated ESMO Clinical Practice Guideline on Early and Locally Advanced NSCLC
Societies
Aug 30, 2025, 21:47
Welcoming Judson Brewer as Keynote Speaker at SIO 2025
Societies
Aug 30, 2025, 21:46
Gina Brown Joins as Keynote on Colorectal Cancer Imaging at EIOC 2025
Science
Aug 30, 2025, 21:45
Alireza Mansouri: ACHIEVE Trial Explores Targeted Therapy for Brain Metastases in Lung Cancer
Insight
Aug 30, 2025, 21:43
Anirban Maitra Congratulates Van Morris on New Cancer Cell Study on Triple Therapy in mCRC
Science
Aug 30, 2025, 21:43
MD Anderson Cancer Center Awarded Over $9M SPORE Grant for Sarcoma Research
Societies
Aug 30, 2025, 21:41
New Kenyan Network of Cancer Organizations Board Outlines Vision for the Next 3 Years
Voices
Aug 30, 2025, 21:38
Shaheenah Dawood: Exciting News on Abemaciclib's Impact on ER+ Breast Cancer at ESMO25
Insight
Aug 30, 2025, 21:36
Raul Cordoba Shared Key ASCO Recommendations for Geriatric Oncology
Voices
Aug 30, 2025, 21:24
Gustave Roussy Prize: €200,000 Award for Cancer Researcher Applications Open
Voices
Aug 30, 2025, 21:14
George Kumar: How Cancer Cells Change Their Identity Under Pressure